Claraphi Advisory Network, LLC Dexcom Inc Transaction History

Claraphi Advisory Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $136,039 - $188,269	-1,446 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$129.87 - $162.82 $11,298 - $14,165	87 Added 6.4%	1,446 $777,000
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $145,018 - $194,581	1,359 New	1,359 $743,000
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $49,062 - $65,730	-629 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $76,885 - $90,924	-805 Reduced 56.14%	629 $259,000
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $72,082 - $121,141	1,150 Added 404.93%	1,434 $582,000
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $13,572 - $21,478	284 New	284 $77,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.